BDR Pharma launches the first generic RUCAPARIB to treat advanced ovarian and prostate cancers in India Kumar Jeetendra | May 27, 2021 Mumbai, 27 May 2021: BDR Pharmaceutical launched BDPARIB (RUCAPARIB) to treat advanced ovarian and prostate cancers today. BDPARIB is the first affordable generic in the India available in the form of a tablet, with the cost of therapy less expensive than any existing drugs in the market. RUCAPARIB is an oral, small-molecule inhibitor of poly …
